Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...

A 45-year-old woman presents with long-standing exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 years.

The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.

While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...

A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...